2021-01-11,Cyclacel Pharmaceuticals Reviews 2020 Achievements and Announces Key Business Objectives for 2021
2020-12-30,Cyclacel Pharmaceuticals to Present at Biotech Showcase Digital 2021
2020-12-22,Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
2020-12-21,"Cyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of Directors"
2020-11-11,Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
2020-11-11,"Cyclacel Pharmaceuticals, Inc. to Host Earnings Call"
2020-11-05,Cyclacel Pharmaceuticals to Release Third Quarter Financial Results
2020-10-26,"Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020"
2020-10-23,"Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer"
2020-10-05,Cyclacel Pharmaceuticals to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
2020-09-21,Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session at the 32nd EORTC-NCI-AACR Symposium 2020
2020-08-16,Edited Transcript of CYCC.OQ earnings conference call or presentation 12-May-20 8:30pm GMT
2020-08-12,Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
2020-08-05,Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results
2020-07-28,Cyclacel (CYCC) to Report Q2 Earnings: What's in the Offing?
2020-07-13,Cyclacels Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer
2020-05-21,3 Strong Buy Biotech Stocks Under $5 With Massive Upside Potential
2020-05-12,Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
2020-05-05,Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results
2020-04-24,Cyclacel Announces Closing of $20 Million Public Offering
2020-04-21,"Company News for Apr 21, 2020"
2020-04-21,CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
2020-04-20,Cyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK Inhibitors to Reduce Runaway Inflammation in COVID-19 Disease
2020-04-14,Cyclacel Announces Reverse Stock Split
2020-03-17,"When Will Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Breakeven?"
2020-03-12,Edited Transcript of CYCC earnings conference call or presentation 26-Feb-20 9:30pm GMT
2020-02-26,Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-20,Cyclacel (CYCC) to Report Q4 Earnings: What's in the Cards?
2020-02-19,Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results
2020-02-10,"Is Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) CEO Paid At A Competitive Rate?"
2020-02-03,Cyclacel Pharmaceuticals to Present at the 2020 BIO CEO & Investor Conference
2020-01-13,Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020
2020-01-06,Cyclacel Pharmaceuticals to Present at Biotech Showcase 2020 in San Francisco
2019-12-11,"Introducing Cyclacel Pharmaceuticals (NASDAQ:CYCC), The Stock That Tanked 92%"
2019-12-09,Cyclacels CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias
2019-12-04,Edited Transcript of CYCC earnings conference call or presentation 13-Nov-19 9:30pm GMT
2019-11-13,Cyclacel Pharmaceuticals Reports Third Quarter 2019 Financial Results
2019-11-07,Cyclacel Pharmaceuticals to Release Third Quarter 2019 Financial Results
2019-11-06,Cyclacel Pharmaceuticals Announces Multiple Clinical Abstracts Selected for Presentation at the ASH 2019 Annual Meeting
2019-10-12,Here's Why We're Watching Cyclacel Pharmaceuticals's (NASDAQ:CYCC) Cash Burn Situation
2019-09-23,Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference
2019-09-09,Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors
2019-09-04,Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference
2019-09-03,Edited Transcript of CYCC earnings conference call or presentation 13-Aug-19 8:30pm GMT
2019-08-28,"Is Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) CEO Paid At A Competitive Rate?"
2019-08-13,Cyclacel Pharmaceuticals Reports Second Quarter 2019 Financial Results
2019-08-13,"The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results"
2019-08-11,"The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO"
2019-08-07,Cyclacel Pharmaceuticals to Release Second Quarter 2019 Financial Results
2019-07-22,Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients
2019-07-04,Edited Transcript of CYCC earnings conference call or presentation 14-May-19 8:30pm GMT
2019-06-26,Some Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shareholders Have Copped A 99% Share Price Wipe Out
2019-05-24,A Look At Benzinga Pro's Most-Searched Tickers For May 24
2019-05-14,Cyclacel Pharmaceuticals Reports First Quarter 2019 Financial Results
2019-05-08,Cyclacel Pharmaceuticals to Release First Quarter 2019 Financial Results
2019-04-29,"Could Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Investor Composition Influence The Stock Price?"
2019-04-09,Edited Transcript of CYCC earnings conference call or presentation 27-Mar-19 8:30pm GMT
2019-04-01,Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019
2019-03-27,Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
2019-03-27,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO"
2019-03-26,Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action
2019-03-26,Cyclacel Provides Clinical Development Update and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com
2019-03-25,Publication Identifies Cyclin E as Key Resistance Pathway to Breast Cancer Treated by CDK4/6 Inhibitors and Thereby Amenable to Treatment by CYC065 CDK2/9 Inhibitor
2019-03-20,Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results
2019-03-13,Cyclacel to Participate in 31st Annual ROTH Conference March 18-19
2019-03-05,Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019
2019-02-05,Cyclacel Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference
2019-01-24,"New Research: Key Drivers of Growth for Square, American International Group, PolyOne, Sonoco Products, Enviva Partners, LP, and Cyclacel Pharmaceuticals  Factors of Influence, Major Initiatives and Sustained Production"
2019-01-07,Cyclacel Pharmaceuticals Reviews 2018 Achievements and Announces Key Business Objectives for 2019
2019-01-03,Edited Transcript of CYCC earnings conference call or presentation 12-Nov-18 9:30pm GMT
2018-12-27,Cyclacel Pharmaceuticals to Present at Biotech Showcase 2019 in San Francisco
2018-12-25,"Does Cyclacel Pharmaceuticals, Inc.s (NASDAQ:CYCC) CEO Pay Reflect Performance?"
2018-12-04,"Consolidated Research: 2018 Summary Expectations for Xencor, Cyclacel Pharmaceuticals, Amicus Therapeutics, Take-Two Interactive Software, CSG Systems International, and Vonage  Fundamental Analysis, Key Performance Indications"
2018-11-13,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut"
2018-11-12,Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
2018-11-06,Cyclacel Pharmaceuticals to Release Third Quarter 2018 Financial Results
2018-10-25,"Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers  New Horizons, Emerging Trends, and Upcoming Developments"
2018-10-23,Cyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
2018-10-04,Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies
2018-09-26,Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference
2018-09-20,What does Cyclacel Pharmaceuticals Incs (NASDAQ:CYCC) Balance Sheet Tell Us About Its Future?
2018-09-12,"Cyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of Directors"
2018-09-10,Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer
2018-09-05,"Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group  New Research Emphasizes Economic Growth"
2018-08-29,Cyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment Conference
2018-08-27,Edited Transcript of CYCC earnings conference call or presentation 9-Aug-18 8:30pm GMT
2018-08-16,"Investor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource  Discovering Underlying Factors of Influence"
2018-08-09,Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results
2018-08-09,"Cyclacel Pharmaceuticals, Inc. to Host Earnings Call"
2018-08-01,Cyclacel Pharmaceuticals to Release Second Quarter 2018 Financial Results
2018-05-25,Who Really Owns Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)?
2018-05-21,Edited Transcript of CYCC earnings conference call or presentation 14-May-18 8:30pm GMT
2018-05-14,Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results
2018-05-14,"Cyclacel Pharmaceuticals, Inc. to Host Earnings Call"
2018-05-14,"Cyclacel Pharmaceuticals Incs (NASDAQ:CYCC) Earnings Dropped -23.81%, Did Its Industry Show Weakness Too?"
2018-05-08,Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results
2018-05-04,"Recent Analysis Shows Lancaster Colony, Calavo Growers, Acuity Brands, Cyclacel Pharmaceuticals, Enbridge Energy Management, and Nasdaq Market Influences  Renewed Outlook, Key Drivers of Growth"
2018-04-17,Cyclacels CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia
2018-04-16,Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
2018-04-13,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More"
